Think Biosolution
Think Biosolution builds an AI-driven chronic disease prevention platform — combining the Hyperdetect predictive engine, Alexa-based NurseAnn voice assistant, and CareManage™ pathway tool — for assisted living, long-term care, and home health care operators serving older residents with cardiac, hypertension, diabetes, or stroke conditions.
- Company typePrivate
- Founded2015
- HeadquartersRochester, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Think Biosolution does
Think Biosolution Limited is a privately held, Ireland-incorporated health-technology company (founded circa 2015-2016) that builds an AI-driven chronic disease prevention platform for the long-term care and assisted living market. The company's core product, branded as the Chronic Disease Prevention Platform with the Hyperdetect AI Predictive Engine, combines Remote Patient Monitoring (RPM), wearable biosensors (PulseR launched 2016 and the QuasaR concept), and the Alexa-based NurseAnn voice-activated nursing assistant to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages in older residents. The CareManage™ module allows nurse managers to define a care pathway strategy and automatically translates it into a personalized care-pathway recommendation for each resident, and the platform integrates with multiple existing EHRs in the long-term care marketplace.
The company reports outcome claims of reducing cost of care by $8,868.23 per resident per year and saving nurse managers up to two hours per patient per month, while also shortening hospital length of stay. Think Biosolution operates from Dublin (NDRC, Digital Exchange) and Rochester, NY (Suite 6385, 260 East Main St), with leadership including CEO Dr. Shourjya Sanyal, CTO Koushik Kumar Nundy, and Product Engineering & Regulatory Affairs Manager Ash Watson.
The business model combines a recurring subscription/enterprise SaaS sale to long-term care operators (quote-based, with no public pricing) with channel partner and OEM/embedded licensing of Hyperdetect to Home Health Care providers and Medical Device manufacturers, supported by dedicated sell-sheet PDFs. Additional revenue is generated from hardware sales of branded wearables. Marketing is dominated by earned media across Irish, US, and European outlets, supplemented by accelerator visibility (Luminate NY, NDRC, InNEVator, Google Adopt a Startup, SPIE), YouTube video, and partner referrals. Capital to date has come primarily from accelerator grants and competition prizes totaling roughly $1.05M (NDRC, Luminate NY, InNEVator, and several smaller post-2018 rounds), with no disclosed venture funding.
Think Biosolution firmographics
Firmographics- Name
- Think Biosolution
- Legal name
- Think Biosolution Limited
- Website
- https://thinkbiosolution.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Think Biosolution builds an AI-driven chronic disease prevention platform — combining the Hyperdetect predictive engine, Alexa-based NurseAnn voice assistant, and CareManage™ pathway tool — for assisted living, long-term care, and home health care operators serving older residents with cardiac, hypertension, diabetes, or stroke conditions.
- Ownership category
- akta.pro rank
Think Biosolution industry classification
Industry- Product category
- Remote Patient Monitoring Software
- NAICS
- Nursing and Residential Care Facilities (623), Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly (6233)
- SIC
- Services-Home Health Care Services (8082)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where Think Biosolution is headquartered
LocationHeadquarters
- HQ city
- Rochester
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Think Biosolution business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Long-Term Care Platform Subscription: Recurring SaaS-style revenue from long-term care and assisted living facilities using the Hyperdetect chronic disease prevention platform. Sells via direct enterprise sales and through channel partners with co-branded sell sheets.
- Channel/OEM Partnerships (Home Health Care & Medical Device): Revenue from Home Health Care partners and Medical Device partners reselling or embedding Hyperdetect technology. Enablement materials and partnership PDFs published for these channels.
- Hardware (Wearable Devices) Sales: One-time sales of branded wearable biosensors (PulseR, QuasaR) that feed data into the chronic disease prevention platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Quote-based enterprise pricing for long-term care facilities |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Think Biosolution product offering
Product offeringCore offering
Think Biosolution provides an AI-driven Chronic Disease Prevention Platform (Hyperdetect) for long-term care and assisted living facilities, combining remote patient monitoring, the CareManage™ care-pathway management tool, the voice-activated NurseAnn (Alexa-based) nursing assistant, and wearable biosensors (PulseR, QuasaR) to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages and translate nurse-defined strategies into personalized resident care pathways.
Product overview
Think Biosolution offers a single unified Chronic Disease Prevention Platform for the long-term care market, delivered as a core AI- and Remote Patient Monitoring-based product with named add-on modules and devices. The core platform delivers end-to-end patient monitoring for older people and residents with cardiac, hypertension, stroke, or diabetic conditions, and incorporates the CareManage™ care pathway management module to translate nurse-defined strategies into personalized care-pathway recommendations. NurseAnn is a voice-activated nursing assistant (built on Alexa) layered onto the platform to collect patient information, assist with vitals collection, and deliver medication reminders. Earlier hardware offerings such as PulseR (launched 2016) and the QuasaR wearable concept extend the platform's remote-monitoring reach.
Differentiator
Problem solved
Functional benefit
Brands
- PulseR: Wearable device launched by Think Biosolution in 2016.
- QuasaR
- NurseAnn
- CareManage
Products and services
- Hyperdetect Chronic Disease Prevention Platform End-to-end AI- and Remote Patient Monitoring-based platform for long-term care facilities, focused on early detection and management of chronic conditions such as cardiac disease, hypertension, and diabetes in older residents and people with cardiac conditions, stroke, or hypertension.
- CareManage
- NurseAnn
- PulseR Wearable health-monitoring product launched in September 2016 for accurate on-the-go health monitoring, referenced in the company's 2016 press release.
- QuasaR Wearable device referenced in 2018 press coverage as a next-generation wearable for continuous health monitoring, positioned as 'the future of wearable devices.'
Quantifiable outcome
- Reduces cost of care by $8,868.23 per resident per year by detecting multiple chronic conditions at mild stages
- +3 more outcomes
Companies that use Think Biosolution
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
Think Biosolution technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Think Biosolution partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- InNEVator (University of Nevada, Reno)minorSelected as one of three IoT companies for the InNEVator 2017 six-week accelerator in Reno, Nevada (launched October 2, 2017). Builds US credibility and connections to Northern Nevada IoT ecosystem.
- Google (Adopt a Startup 2017)minorSelected as one of 31 start-ups in Google's "Adopt a Startup 2017" mentorship program. Provides GTM mentorship and exposure rather than capital.
- SPIE Startup Challenge 2017minorSemi-finalist in the SPIE Startup Challenge 2017 at Photonics West (covered by BioOptics World and SPIE). Industry competition relevant to optics/photonics positioning of the wearable biosensor products.
- Home Health Care Channel Partners (unnamed)coreChannel partner program targeting Home Health Care resellers/distributors, supported by a dedicated Sell_Sheet_Hyperdetect_HHC.pdf sales sheet and listed as a "Digital Sales Support Material" on the Long Term Care page. Partners resell or co-deliver Hyperdetect-enabled home monitoring.
- Medical Device OEM Partners (unnamed)coreOEM/embedded channel for medical device manufacturers to integrate or white-label Hyperdetect into their devices. Supported by a dedicated Partnership_Hyperdetect_MedDevice.pdf and listed under "Digital Sales Support Material" alongside the Home Health Care sell sheet.
- Long-Term Care Partner Logos (7 unnamed organizations)minorSeven partner logos are displayed under the "PARTNERS" banner on the homepage (thinkbiosolution.com) but the underlying partner names are not captioned in the source. Likely a mix of channel, technology, and pilot partners within the long-term care ecosystem.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Think Biosolution competitors and assessment
Company assessmentDirect peers
- Biofourmis: AI-based predictive analytics platform layered on continuous biosensor data for chronic and post-acute care. Comparable in combining AI predictive engine + wearable biosensors for chronic-disease management.
- CarePredict: AI-driven wearable and analytics platform for senior living and assisted living populations, predicting health declines and ADL changes. Closely comparable to Think Biosolution's Hyperdetect approach of combining wearables + AI for early chronic-condition detection in older residents.
- Current Health (Best Buy Health): AI-enabled RPM platform combining a wearable and predictive analytics for chronic and post-acute care; acquired by Best Buy to scale hospital-at-home. Comparable AI + wearable stack for chronic-disease patients.
- Health Recovery Solutions (HRS): RPM platform focused on chronic disease management (cardiac, COPD, diabetes) for home health and post-acute care. Overlaps with Think Biosolution's HHC channel and chronic-condition use cases.
- VitalConnect: Wearable biosensor patch (VitalPatch) plus remote cardiac and vital-sign monitoring platform sold to hospitals and home health. Comparable to Think Biosolution's PulseR/QuasaR wearables feeding a chronic-disease platform.
- EarlySense: Contact-free continuous monitoring sensors and analytics for skilled nursing, assisted living, and hospitals. Direct competitor in the long-term care RPM and early-detection niche that Think Biosolution targets.
Emerging players
- Aiva Health: Voice-first care assistant for senior living and home health using smart speakers. Directly comparable to Think Biosolution's NurseAnn Alexa-based nursing assistant for medication reminders and resident interaction.
Broad incumbents
- Vivify Health (Optum): Established RPM platform from Optum/UHG offering chronic-care remote monitoring to health systems and payers. Competes broadly with Think Biosolution's chronic-disease platform via scale and payer relationships.
- Tunstall Healthcare: European-headquartered telecare and RPM provider with deep penetration in assisted living and home health. Comparable vertically focused on senior populations; Think Biosolution's Irish HQ and long-term care focus put it in overlapping European and US geographies.
- Philips Remote Patient Monitoring: Broad RPM portfolio from Philips covering hospital, home, and chronic-disease monitoring. Represents the incumbent scale competitor that Think Biosolution must displace in long-term care procurement.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights5 records
Customer concentration
Think Biosolution social profiles
Digital presenceThink Biosolution financial estimates
Financial estimateRevenue estimate
Valuation estimate
Think Biosolution leadership team
Management profileNumber of profiles
Profiles3 records
Think Biosolution funding detail
Funding detailFunding overview
Funding rounds7 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Think Biosolution M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Think Biosolution
What does Think Biosolution do?
Think Biosolution provides an AI-driven Chronic Disease Prevention Platform (Hyperdetect) for long-term care and assisted living facilities, combining remote patient monitoring, the CareManage™ care-pathway management tool, the voice-activated NurseAnn (Alexa-based) nursing assistant, and wearable biosensors (PulseR, QuasaR) to detect co-morbid chronic conditions (cardiac, hypertension, diabetes, stroke) at mild stages and translate nurse-defined strategies into personalized resident care pathways.
Is Think Biosolution a public or private company?
Think Biosolution is a private company. It is classified as venture growth investor backed and is currently operating.
When was Think Biosolution founded?
Think Biosolution was founded in 2015. It employs 1 to 10 people.
Where is Think Biosolution based?
Think Biosolution is headquartered in Rochester, United States, in the North America region.
How does Think Biosolution make money?
Three revenue lines are on record. Long-Term Care Platform Subscription is the primary driver. The others are channel/OEM Partnerships (Home Health Care & Medical Device) and hardware (Wearable Devices) Sales.
Who are Think Biosolution's main competitors?
Direct peers on record are Biofourmis, CarePredict, Current Health (Best Buy Health), Health Recovery Solutions (HRS), VitalConnect and EarlySense. Aiva Health is listed as an emerging player. Broad incumbents are Vivify Health (Optum), Tunstall Healthcare and Philips Remote Patient Monitoring.
Does Think Biosolution have an API?
No public API is recorded for Think Biosolution.
What industry is Think Biosolution in?
Think Biosolution's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 623 and its SIC code is 8082.